China Likely To Strengthen Distribution Regulations To Force Consolidation
This article was originally published in The Pink Sheet Daily
Executive Summary
New regulatory hurdles for Chinese drug distributors would likely be prohibitive for many smaller players and would drive bigger companies to consolidate the fragmented market.